GLAXOSMITHKLINE PHARMACEUTICALS LTD.
BSE: 500660
Shareholding Trends
Ownership split
PromoterPublicOthers
Institutional detail
FII / FPIDII
Q2 FY27
Corporate Events
Board MeetingGLAXO
20263Nov
Board Meeting
The Board of Directors meeting is scheduled to consider, app…
BSE Filing ↗ Board MeetingGLAXO
20263Aug
Board Meeting
A meeting of the Board of Directors of our Company will be h…
BSE Filing ↗ Board MeetingGLAXO
20251Aug
Board Meeting
Board Meeting Intimation, Un-Audited Financial Results for t…
BSE Filing ↗ Board MeetingGLAXO
202514Feb
Board Meeting
Consider and approve Un-audited financial results for the th…
BSE Filing ↗ Board MeetingGLAXO
202429Oct
Board Meeting
consider and approve Unaudited financial results for the sec…
BSE Filing ↗ Board MeetingGLAXO
20242Aug
Board Meeting
Consider and approve Un-Audited Financial Results for the fi…
BSE Filing ↗ Board MeetingGLAXO
202412Feb
Board Meeting
consider and approve Un-Audited Financial Results for the th…
BSE Filing ↗ Board MeetingGLAXO
20239Nov
Board Meeting
Consideration and approval of Un-Audited Financial Results f…
BSE Filing ↗